Seer (SEER) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 May, 2026Executive summary
Board unanimously rejected a revised unsolicited acquisition proposal from the Radoff-JEC Group, citing it was not in the best interests of stockholders.
Leadership reaffirmed confidence in the current standalone strategy and ongoing business priorities.
Forward-looking statements highlight continued focus on advancing the company’s proteomics platform and capturing future opportunities.
Voting matters and shareholder proposals
Preliminary proxy statement for the 2026 Annual Meeting has been filed, with a definitive proxy statement and BLUE proxy card to be furnished to stockholders.
Stockholders are encouraged to read all proxy materials and related documents when available, as they contain important information for voting decisions.
Board of directors and corporate governance
Board’s decision to reject the acquisition proposal was made in consultation with independent financial and legal advisors.
Board and management emphasized alignment on the go-forward strategy and commitment to stockholder interests.
Latest events from Seer
- Board seeks support for nominees, emphasizing innovation and disciplined capital allocation.SEER
Proxy filing15 Jun 2026 - Board urges support for its nominees, citing innovation and long-term value over activist proposals.SEER
Proxy filing15 Jun 2026 - Board urges support for its seven nominees amid competing proxy solicitation.SEER
Proxy filing11 Jun 2026 - Proxy filing urges support for incumbent directors and rejects activist proposals as value-destructive.SEER
Proxy filing3 Jun 2026 - Proxy contest pits board’s long-term strategy against activists’ push for board seats and a sale.SEER
Proxy filing3 Jun 2026 - Board urges support for its nominees and proposals, rejecting activist alternatives and acquisition bids.SEER
Proxy filing3 Jun 2026 - Shareholders are urged to elect three independent directors and oppose executive pay and the NOL Pill.SEER
Proxy filing1 Jun 2026 - Board unanimously rejects revised unsolicited acquisition proposal; details disclosed.SEER
Proxy filing22 May 2026 - Shareholders are urged to elect three independent directors and oppose executive pay and the NOL Pill.SEER
Proxy filing21 May 2026